Survodutide

Description

Survodutide is a dual GLP-1/glucagon receptor agonist originally developed for research into metabolic dysfunction-associated steatotic liver disease (MASLD) as well as obesity. Its glucagon-receptor activity is specifically of interest to hepatology-adjacent research, since glucagon signalling influences hepatic fat oxidation independently of the appetite-suppressing GLP-1 pathway.

Because survodutide sits at the intersection of metabolic and liver-disease research, it’s frequently requested by labs studying fatty liver models alongside classic obesity endpoints — a narrower and more specific research niche than single-pathway GLP-1 compounds.

Supplied for laboratory research only, not for human use. Reconstitute with bacteriostatic water and store refrigerated per standard peptide handling.